과제정보
연구비 지원기관: 상지대학교 연구비 지원기관은 연구의 설계, 자료 수집과 분석, 출판결정, 원고 작성에 어떠한 영향도 없었음을 밝힌다.
참고문헌
- Elkouzi A, Vedam-Mai V, Eisinger RS, Okun MS. Emerging therapies in Parkinson disease - repurposed drugs and new approaches. Nat Rev Neurol. 2019 ; 15(4) : 204-23. https://doi.org/10.1038/s41582-019-0155-7
- Tysnes OB, Storstein A. Epidemiology of Parkinson's disease. J Neural Transm (Vienna). 2017 ; 124(8) : 901-5. https://doi.org/10.1007/s00702-017-1686-y
- Del Rey NL, Quiroga-Varela A, Garbayo E, Carballo-Carbajal I, Fernandez-Santiago R, Monje MHG, et al. Advances in Parkinson's Disease: 200 Years Later. Front Neuroanat. 2018 ; 12 : 113. https://doi.org/10.3389/fnana.2018.00113
- Cacciatore I, Ciulla M, Marinelli L, Eusepi P, Di Stefano A. Advances in prodrug design for Parkinson's disease. Expert Opin Drug Discov. 2018 ; 13(4) : 295-305. https://doi.org/10.1080/17460441.2018.1429400
- Murphy DL, Fox MA, Timpano KR, Moya PR, Ren-Patterson R, Andrews AM, et al. How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology. 2008 ; 55(6) : 932-60. https://doi.org/10.1016/j.neuropharm.2008.08.034
- Montanez S, Daws LC, Gould GG, Frazer A. Serotonin (5-HT) transporter (SERT) function after graded destruction of serotonergic neurons. J Neurochem. 2003 ; 87(4) : 861-7. https://doi.org/10.1046/j.1471-4159.2003.02032.x
- Martel F, Monteiro R, Lemos C. Uptake of serotonin at the apical and basolateral membranes of human intestinal epithelial (Caco-2) cells occurs through the neuronal serotonin transporter (SERT). J Pharmacol Exp Ther. 2003 ; 306(1) : 355-62. https://doi.org/10.1124/jpet.103.049668
- Koren G, Ornoy A. Clinical implications of selective serotonin reuptake inhibitors-selective serotonin norepinephrine reuptake inhibitors pharmacogenetics during pregnancy and lactation. Pharmacogenomics. 2018 ; 19(14) : 1139-45. https://doi.org/10.2217/pgs-2018-0076
- Zahavi AY, Sabbagh MA, Washburn D, Mazurka R, Bagby RM, Strauss J, et al. Serotonin and Dopamine Gene Variation and Theory of Mind Decoding Accuracy in Major Depression: A Preliminary Investigation. PLoS One. 2016 ; 11(3) : e0150872. https://doi.org/10.1371/journal.pone.0150872
- Wang JY, Fan QY, He JH, Zhu SG, Huang CP, Zhang X, et al. SLC6A4 Repeat and Single-Nucleotide Polymorphisms Are Associated With Depression and Rest Tremor in Parkinson's Disease: An Exploratory Study. Front Neurol. 2019 ; 10 : 333. https://doi.org/10.3389/fneur.2019.00333
- Albani D, Vittori A, Batelli S, Polito L, De Mauro S, Galimberti D, et al. Serotonin transporter gene polymorphic element 5-HTTLPR increases the risk of sporadic Parkinson's disease in Italy. Eur Neurol. 2009 ; 62(2) : 120-3. https://doi.org/10.1159/000222784
- Mossner R, Schmitt A, Syagailo Y, Gerlach M, Riederer P, Lesch KP. The serotonin transporter in Alzheimer's and Parkinson's disease. J Neural Transm Suppl. 2000 ; (60) : 345-50.
- Choi YG, Lim S. N(varepsilon)-(carboxymethyl)lysine linkage to alpha-synuclein and involvement of advanced glycation end products in alpha-synuclein deposits in an MPTP-intoxicated mouse model. Biochimie. 2010 ; 92(10) : 1379-86. https://doi.org/10.1016/j.biochi.2010.06.025
- Paus S, Seeger G, Brecht HM, Koster J, El-Faddagh M, Nothen MM, et al. Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease. Mov Disord. 2004 ; 19(6) : 705-7. https://doi.org/10.1002/mds.20134
- Wile DJ, Agarwal PA, Schulzer M, Mak E, Dinelle K, Shahinfard E, et al. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies. Lancet Neurol. 2017 ; 16(5) : 351-9. https://doi.org/10.1016/s1474-4422(17)30056-x